23
MedPacto
235980.KQ·KOSDAQSeoul KRFounded 2000100 employees
Micro CapbiotechPublicOncologyPulmonology
Platform: TGF-β Onc
Market Cap
$0.1B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (235980.KQ)
Loading 235980.KQ stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Voxazasiran | 235-7325 | Phase 1 | 1 | PI3Kα | PAHET | ||
| Cevivorutinib | 235-8749 | Phase 2/3 | 2 | KIF18A | Hemophilia ACLL |
SEC Filings & Financial Documents
SEC filings are not available for KOSDAQ-listed companies.
MedPacto trades on KOSDAQ (KR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)